RECTAL ADENOCARCINOMA

This adverse event was reported 605 times

These drugs are most commonly taken by patients reporting RECTAL ADENOCARCINOMA:

# Drug Count
0 DEXAMETHASONE 68
1 DEXAMETHASONE 1.5 MG 68
2 LENALIDOMIDE 66
3 BEVACIZUMAB 60
4 FLUOROURACIL 60
5 FLUOROURACIL CREAM, 0.5% 58
6 OXALIPLATIN 55
7 ADALIMUMAB 47
8 METHOTREXATE SODIUM 38
9 METHOTREXATE 33
See all common drugs associated with RECTAL ADENOCARCINOMA